HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshinobu Iwasaki Selected Research

7- chloro- 3- imino- 5- methyl- 2- azabicyclo(4.1.0)heptane

10/2008Effect of inducible nitric oxide synthase on apoptosis in Candida-induced acute lung injury.
4/2007A novel potent inhibitor of inducible nitric oxide synthase, ONO-1714, reduces hyperoxic lung injury in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshinobu Iwasaki Research Topics

Disease

22Neoplasms (Cancer)
02/2019 - 01/2002
11Ischemia
08/2010 - 01/2003
7Infarction (Infarctions)
04/2011 - 03/2004
7Cerebral Infarction
08/2010 - 09/2003
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 12/2006
6Ischemic Stroke
10/2011 - 12/2008
5Glioma (Gliomas)
09/2011 - 05/2006
5Brain Infarction
04/2011 - 03/2004
5Spinal Cord Injuries (Spinal Cord Injury)
06/2010 - 09/2003
5Aneurysm (Aneurysms)
05/2009 - 05/2003
5Lung Injury
10/2008 - 12/2003
4Fever (Fevers)
03/2022 - 09/2011
4Carotid Artery Diseases
05/2009 - 06/2004
4Acute Lung Injury
10/2008 - 12/2003
3Pneumonia (Pneumonitis)
03/2022 - 10/2017
3Inflammation (Inflammations)
03/2022 - 04/2005
3Traumatic Brain Injuries (Traumatic Brain Injury)
04/2012 - 04/2010
3Pathologic Constriction (Stenosis)
10/2011 - 01/2005
3Pain (Aches)
08/2011 - 10/2007
3Central Nervous System Diseases (CNS Diseases)
04/2011 - 04/2010
3Carotid Stenosis (Carotid Artery Stenosis)
01/2011 - 02/2005
3Stomach Neoplasms (Stomach Cancer)
06/2010 - 12/2006
3Moyamoya Disease (Moya-Moya Disease)
06/2010 - 12/2004
3Hematoma
10/2009 - 05/2003
3Intervertebral Disc Displacement (Herniated Disc)
06/2009 - 12/2003
3Lung Diseases (Lung Disease)
03/2009 - 05/2006
3Germinoma
07/2008 - 09/2004
3Nervous System Diseases (Neurological Disorders)
05/2006 - 08/2004
3Brain Ischemia (Cerebral Ischemia)
01/2005 - 03/2004
2Hypereosinophilic Syndrome (Loeffler Endocarditis)
02/2021 - 11/2020
2Lung Neoplasms (Lung Cancer)
01/2021 - 01/2019
2Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2021 - 01/2020
2Spondylosis
07/2010 - 09/2008
2Cognitive Dysfunction
08/2009 - 10/2007
2Hyperemia
06/2009 - 06/2009
2Chronic Obstructive Pulmonary Disease (COPD)
03/2009 - 05/2007
2Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation)
09/2008 - 11/2004
2Hyperoxia
04/2007 - 01/2007
2Neurologic Manifestations (Neurological Manifestations)
02/2007 - 10/2004
2Diabetes Mellitus
09/2006 - 01/2002
2Glioblastoma (Glioblastoma Multiforme)
05/2006 - 10/2003
2Infections
01/2005 - 01/2002
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2004 - 09/2003

Drug/Important Bio-Agent (IBA)

6Biological ProductsIBA
04/2012 - 10/2003
6Oxygen (Dioxygen)IBA
05/2009 - 12/2003
5Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2017 - 12/2003
5Proteins (Proteins, Gene)FDA Link
12/2007 - 12/2004
4CytokinesIBA
03/2022 - 04/2005
4Cisplatin (Platino)FDA LinkGeneric
02/2019 - 12/2006
4Etoposide (VP 16)FDA LinkGeneric
02/2019 - 12/2002
4Acetazolamide (Diamox)FDA LinkGeneric
05/2009 - 12/2003
4Reactive Oxygen Species (Oxygen Radicals)IBA
12/2008 - 12/2004
3Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 01/2019
3Docetaxel (Taxotere)FDA Link
01/2019 - 12/2006
3Therapeutic UsesIBA
04/2012 - 04/2010
3ChloridesIBA
06/2010 - 02/2008
3Expectorants (Mucolytics)IBA
03/2009 - 05/2006
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2008 - 04/2007
3IfosfamideFDA LinkGeneric
07/2008 - 12/2002
3Cytochromes c (Cytochrome c)IBA
01/2007 - 01/2003
3Neuroprotective AgentsIBA
01/2005 - 03/2004
3triphenyltetrazoliumIBA
01/2005 - 03/2004
2mepolizumabIBA
02/2021 - 11/2020
2benralizumabIBA
02/2021 - 11/2020
2EnzymesIBA
01/2021 - 01/2002
2pembrolizumabIBA
01/2021 - 01/2020
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2020
2Cytotoxins (Cytolysins)IBA
01/2019 - 01/2019
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2012 - 05/2009
21-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2011 - 05/2008
2SteroidsIBA
09/2011 - 02/2007
2AcidsIBA
09/2011 - 05/2008
2Aligeron (AS 2)IBA
08/2009 - 05/2009
2TitaniumIBA
05/2009 - 10/2008
2Ambroxol (Mucosolvan)IBA
03/2009 - 05/2006
2EdaravoneIBA
12/2008 - 12/2004
2Superoxides (Superoxide)IBA
12/2008 - 12/2004
2Free Radical ScavengersIBA
12/2008 - 12/2004
27- chloro- 3- imino- 5- methyl- 2- azabicyclo(4.1.0)heptaneIBA
10/2008 - 04/2007
2Capsules (Microcapsules)IBA
09/2008 - 07/2003
2IceIBA
07/2008 - 02/2007
2Peroxynitrous Acid (Peroxynitrite)IBA
04/2007 - 12/2003
2Nitric Oxide Synthase (NO Synthase)IBA
04/2007 - 12/2003
2Messenger RNA (mRNA)IBA
12/2006 - 10/2003
2Carboplatin (JM8)FDA LinkGeneric
10/2005 - 12/2002
2Adrenal Cortex Hormones (Corticosteroids)IBA
05/2005 - 07/2004

Therapy/Procedure

20Therapeutics
03/2022 - 12/2002
16Radiotherapy
02/2019 - 10/2002
12Transplantation
04/2011 - 09/2003
11Drug Therapy (Chemotherapy)
02/2019 - 12/2002
6Decompression
06/2009 - 10/2003
4Carotid Endarterectomy
10/2011 - 01/2005
4Craniotomy
09/2006 - 05/2003
3Photochemotherapy (Photodynamic Therapy)
09/2011 - 05/2008
3Cell Transplantation
04/2011 - 10/2007
2Surgical Decompression
07/2010 - 09/2008
2Laminectomy
10/2009 - 05/2008
2Ligation
05/2009 - 01/2005
2Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
10/2005 - 12/2002
2Stents
09/2005 - 02/2005